Literature DB >> 18184144

The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

P Hardelid1, M Cortina-Borja, A Munro, H Jones, M Cleary, M P Champion, Y Foo, C R Scriver, C Dezateux.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism (OMIM 261600). Treatment with a low-phenylalanine diet following early ascertainment by newborn screening prevents impaired cognitive development, the major disease phenotype in PKU. The overall birth prevalence of PKU in European, Chinese and Korean populations is approximately 1/10,000. Since the human PAH locus contains PKU-causing alleles and polymorphic core haplotypes that describe and corroborate an out-of-Africa range expansion in modern human populations, it is of interest to know the prevalence of PKU in different ethnic groups with diverse geographical origin. We estimated PKU prevalence in South East England, where a sizeable proportion of the population are of Sub-Saharan African or South Asian ancestry. Over the period 1994 to 2004 167 children were diagnosed with PKU. Using birth registration and census data to derive denominators, PKU birth prevalence per 10,000 live births (95% Bayesian credible intervals) was estimated to be 1.14 (0.96-1.33) among white, 0.11 (0.02-0.37) among black, and 0.29 (0.10-0.63) among Asian ethnic groups. This suggests that PKU is up to an order of magnitude less prevalent in populations with Sub-Saharan African and South Asian ancestry that have migrated to the UK.

Entities:  

Mesh:

Year:  2008        PMID: 18184144     DOI: 10.1111/j.1469-1809.2007.00389.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  17 in total

1.  Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer.

Authors:  Stuart Lavery; Dima Abdo; Mara Kotrotsou; Geoff Trew; Michalis Konstantinidis; Dagan Wells
Journal:  JIMD Rep       Date:  2012-03-31

2.  Transition of young adults with phenylketonuria from pediatric to adult care.

Authors:  Ulrike Mütze; Annika Roth; Johannes F W Weigel; Skadi Beblo; Christoph G Baerwald; Peter Bührdel; Wieland Kiess
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

Review 3.  What we know that could influence future treatment of phenylketonuria.

Authors:  C N Sarkissian; A Gámez; C R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-08-03       Impact factor: 4.982

4.  Melanoma cases demonstrate increased carrier frequency of phenylketonuria/hyperphenylalanemia mutations.

Authors:  Joshua Arbesman; Sairekha Ravichandran; Pauline Funchain; Cheryl L Thompson
Journal:  Pigment Cell Melanoma Res       Date:  2018-03-12       Impact factor: 4.693

Review 5.  Phenylketonuria.

Authors:  Francjan J van Spronsen; Nenad Blau; Cary Harding; Alberto Burlina; Nicola Longo; Annet M Bosch
Journal:  Nat Rev Dis Primers       Date:  2021-05-20       Impact factor: 52.329

6.  Selection for translation efficiency on synonymous polymorphisms in recent human evolution.

Authors:  Yedael Y Waldman; Tamir Tuller; Alon Keinan; Eytan Ruppin
Journal:  Genome Biol Evol       Date:  2011-07-29       Impact factor: 3.416

7.  Phenylketonuria screening and management in southeastern Europe - survey results from 11 countries.

Authors:  Mojca Zerjav Tansek; Urh Groselj; Natalija Angelkova; Dana Anton; Ivo Baric; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Miljanovic; Florentina Moldovanu; Mariana Muresan; Michaela Nanu; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

8.  Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.

Authors:  Antoine Regnault; Alberto Burlina; Amy Cunningham; Esther Bettiol; Flavie Moreau-Stucker; Khadra Benmedjahed; Annet M Bosch
Journal:  Orphanet J Rare Dis       Date:  2015-05-10       Impact factor: 4.123

9.  Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria.

Authors:  Sven F Garbade; Nan Shen; Nastassja Himmelreich; Dorothea Haas; Friedrich K Trefz; Georg F Hoffmann; Peter Burgard; Nenad Blau
Journal:  Genet Med       Date:  2018-07-12       Impact factor: 8.822

10.  Quality of life among parents of children with phenylketonuria (PKU).

Authors:  Astrid Fidika; Christel Salewski; Lutz Goldbeck
Journal:  Health Qual Life Outcomes       Date:  2013-03-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.